Back to Search
Start Over
Lessons From a Multi site International Trial in the Caribbean and South America of an HIV-1 Canarypox Vaccine (ALVAC-HIV vCP1452) With or Without Boosting With MN rgp120.
- Source :
-
JAIDS: Journal of Acquired Immune Deficiency Syndromes . 10/1/2007, Vol. 46 Issue 2, p222-230. 9p. 4 Charts, 1 Graph. - Publication Year :
- 2007
-
Abstract
- The article evaluates the safety and immunogenicity of a clade B-derived, live canarypox HIV vaccine, vCP1452. It reports on the first multicenter, international National Institutes of Allergy and Infectious Diseases-sponsored HIV vaccine trial in Brazil, Haiti, Peru and Trinidad. The vaccine was administered alone or with a heterologous boost of MN rgp120 glycoprotein.
- Subjects :
- *AIDS vaccines
*HIV infections
*VACCINATION
*PREVENTION of communicable diseases
Subjects
Details
- Language :
- English
- ISSN :
- 15254135
- Volume :
- 46
- Issue :
- 2
- Database :
- Academic Search Index
- Journal :
- JAIDS: Journal of Acquired Immune Deficiency Syndromes
- Publication Type :
- Academic Journal
- Accession number :
- 27021630
- Full Text :
- https://doi.org/10.1097/QAI.0b013e318149297d